Interaction between genetic factors, Porphyromonas gingivalis and microglia to promote Alzheimer’s disease

References

• Soscia SJ, Kirby E, Washicosky KJ, et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010;5(3):09505.
   Web of Science ®Google Scholar
• Kumar DKV, Choi SH, Washicosky KJ, et al. Amyloid-ß peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med. 2016;8(340):340ra72.
   PubMed Web of Science ®Google Scholar
• Singhrao SK, Olsen I. Assessing the role of Porphyromonas gingivalis in periodontitis to determine a causative relationship with Alzheimer’s disease. J Oral Microbiol. 2019;11(1):1563405.
   PubMed Web of Science ®Google Scholar
• Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5:eaaa3333.
   Web of Science ®Google Scholar
• Olsen I, Singhrao SK. Is there a link between genetic defects in the complement cascade and Porphyromonas gingivalis in Alzheimer’s disease? J Oral Microbiol. 2019;12(1):1676486.
   PubMed Web of Science ®Google Scholar
• Chalmers JM, Hodge C, Fuss JM, et al. The prevalence and experience of oral diseases in Adelaide nursing home residents. Aust Dent J. 2002;47(2):123–10.
   Web of Science ®Google Scholar
• Olsen I, Potempa J. Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases. J Oral Microbiol. 2014;6. DOI:10.3402/jom.v6.24800.
   Web of Science ®Google Scholar
• Ilievski V, Zuchowska PK, Green SJ, et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS One. 2018;13(10):e0204941.
   PubMed Web of Science ®Google Scholar
• Haditsch U, Roth T, Rodriguez L, et al. Alzheimer’s disease-like neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains. J Alzheimer’s Dis. 2020;75:1361–1376.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu Z, Nakanishi Y, et al. Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice. Sci Rep. 2017;7(1):11759. Liu Y, Wu Z, Nakanishi Y, et al. Author Correction: Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice. Sci Rep. 2018; 8: 10304.
   PubMedGoogle Scholar
• Nonaka S, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis induce microglia migration through endosomal signaling by protease-activated receptor 2. Neurochem Int. 2020;104840. DOI:10.1016/j.neuint.2020.104840.
   Web of Science ®Google Scholar
• Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8(2):205–216.
   PubMed Web of Science ®Google Scholar
• Stomrud E, Björkqvist M, Janciauskiene S, et al. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res Ther. 2010;2(3):20.
   Web of Science ®Google Scholar
• Sochocka M, Diniz BS, Leszek J, et al. Inflammatory response in the CNS: friend or foe? Mol Neurobiol. 2017;54(10):8071–8089.
   PubMed Web of Science ®Google Scholar
• Mroczko B, Groblewska M, Barcikowska M. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. J Alzheimers Dis. 2013;37(2):273–283.
   Web of Science ®Google Scholar
• Irshad M, Scheres N, Anssari Moin D, et al. Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis. J Periodontal Res. 2013;48(5):647–656.
   PubMed Web of Science ®Google Scholar
• Inaba H, Sugita H, Kuboniwa M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol. 2014;16(1):131–145.
   PubMed Web of Science ®Google Scholar
• Inaba H, Amano A, Lamont RJ, et al. Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis. Med Microbiol Immunol. 2015;204(5):605–612.
   Web of Science ®Google Scholar
• Poole S, Singhrao SK, Kesavalu L, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36(4):665–677.
   PubMed Web of Science ®Google Scholar
• Sato Y, Kishi J, Suzuki K, et al. Sonic extracts from a bacterium related to periapical disease activate gelatinase A and inactivate tissue inhibitor of metalloproteinases TIMP-1 and TIMP-2. Int Endod J. 2009;42(12):1104–1111.
   Web of Science ®Google Scholar
• Bozkurt SB, Hakki SS, Hakki EE, et al. Porphyromonas gingivalis lipopolysaccharide induces a pro-inflammatory human gingival fibroblast phenotype. Inflammation. 2017;40(1):144–153.
   Web of Science ®Google Scholar
• Green K. Microbial function in the healthy brain. [cited 2019 Jan 8]. https:faculty.sites.uci.edu/kimgreen/bio/microglia-in-the-healthy-brain
   Google Scholar
• Norden DM, Godbout JP. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol. 2013;39:19–34.
   Web of Science ®Google Scholar
• Réu P, Khosravi A, Bernard S, et al. The lifespan and turnover of microglia in the human brain. Cell Rep. 2017;20(4):779–784.
   PubMed Web of Science ®Google Scholar
• Poole S, Singhrao SK, Chukkapalli S, et al. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE−/- mice brains. J Alzheimers Dis. 2015;43(1):67–80.
   PubMed Web of Science ®Google Scholar
• Velsko IM. Periodontal pathogen-induced atherosclerosis in ApoE−/- and integrin β 6−/- mice (PhD thesis). University of Florida; 2014.
   Google Scholar
• Wendeln AC, Degenhardt K, Kaurani L, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556(7701):332–338.
   PubMed Web of Science ®Google Scholar
• Sparks Stein P, Steffen MJ, Smith C, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease. Alzheimers Dement. 2012;8(3):196–203.
   PubMed Web of Science ®Google Scholar
• Chen C-K, Wu Y-T, Chang Y-C. Association between chronic periodontitis and the risk of Alzheimer’s disease: a retrospective, population-based, matched cohort study. Alzheimers Res Ther. 2017;9:56.
   PubMed Web of Science ®Google Scholar
• Singhrao SK, Harding A, Poole S, et al. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators Inflammation. 2015;2015:137357.
   PubMed Web of Science ®Google Scholar
• Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;53(2):1181–1194.
   PubMed Web of Science ®Google Scholar
• Hammond TR, Dufort C, Dissing-Olesen L, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:1–19.
   Web of Science ®Google Scholar
• Keren-Schaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell. 2017;169:1276–1290.e17.
   Web of Science ®Google Scholar
• Bennett JP Jr, Keeney PM, Brohawn DG. RNA sequencing reveals small and variable contributions of infectious agents to transcriptomes of postmortem nervous tissues from amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease subjects, and increased expression of genes from disease-activated microglia. Front Neurosci. 2019;13:235.
   PubMed Web of Science ®Google Scholar
• Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013;39(1):3–18.
   PubMed Web of Science ®Google Scholar
• Wang WY, Tan MS, Yu JT, et al. Role of pro- inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med. 2015;3(10):136.
   PubMed Web of Science ®Google Scholar
• Bronzuoli MR, Iacomino A, Steardo L, et al. Targeting neuroinflammation in Alzheimer’s disease. J Inflamm Res. 2016;9:199–208.
   Web of Science ®Google Scholar
• Singhrao SK, Neal JW, Morgan BP, et al. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington’s disease. Exp Neurol. 1999;159(2):362–376.
   PubMed Web of Science ®Google Scholar
• Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712–716.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Jawaid A, Henstridge CM, et al. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron. 2017;95(2):297–308.e6.
   Web of Science ®Google Scholar
• Vasek MJ, Garber C, Dorsey D, et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534(7608):538–543.
   PubMed Web of Science ®Google Scholar
• Singhrao SK, Chukkapalli S, Poole S, et al. Chronic Porphyromonas gingivalis infection accelerates the occurrence of age-related granules in ApoE−/- mice brains. J Oral Microbiol. 2017;9(1):1270602.
   PubMed Web of Science ®Google Scholar
• Jansen IE, Svage JE, Watanabe K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51(3):404–413.
   PubMed Web of Science ®Google Scholar
• Carter C. Alzheimer’s disease: APP, gamma secretase, APOE, Clu, CR1, PICALM, ABCA7, BINI1, CD2AP, CD33, EPHA1, and MS4A2, and their relationships with Herpes simplex, C. pneumoniae, other suspect pathogens, and the immune system. Int J Alzheimer’s Dis. 2011;2011:501862.
   PubMedGoogle Scholar
• Hong S, Dissing-Olesen L, Stevens B. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol. 2016;36:128–134.
   Web of Science ®Google Scholar
• Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at GLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1088–1093.
   PubMed Web of Science ®Google Scholar
• Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1094–1099.
   PubMed Web of Science ®Google Scholar
• Hakobyan S, Harding K, Aiyaz M, et al. Complement biomarkers as predictors of disease progression in Alzheimer’s disease. J Alzheimers Dis. 2016;54(2):707–716.
   Web of Science ®Google Scholar
• Giri M, Zhang M, Lü Y, et al. Genes associated with Alzheimer’s disease: an overview and current status. Clin Interv Aging. 2016;11:665–681.
   PubMed Web of Science ®Google Scholar
• Karch CM, Goate AM. Alzheimer’s disease risk genes and mechanisms of gene pathogenesis. Biol Psychiatry. 2015;77(1):43–51.
   PubMed Web of Science ®Google Scholar
• Shim YJ, Kang BH, Choi BK, et al. Clusterin induces the secretion of TNF-α and the chemotactic migration of macrophages. Biochim Biophys Res Commun. 2012;422(1):200–205.
   Web of Science ®Google Scholar
• Hajischengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10(5):497–506.
   Web of Science ®Google Scholar
• Malik M, Simpson JF, Parikh I, et al. CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33(33):13320–13325.
   PubMed Web of Science ®Google Scholar
• Griciuc A, Serrano-Pozo A, Parrado AR, et al. Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78:631–643.
   PubMed Web of Science ®Google Scholar
• Hallén U, Björkner AE, Hallberg EC. Binding of the periodontitis associated bacterium Porphyromonas gingivalis to glycoproteins from human epithelial cells. Oral Microbiol Immunol. 2008;23(5):367–371.
   Google Scholar
• Zaric SS, Lappin MJ, Fulton CR, et al. Sialylation of Porphyromonas gingivalis LPS and its effect on bacterial-host interactions. Innate Immun. 2017;23(3):319–326.
   Web of Science ®Google Scholar
• Repik A, Pincus SE, Ghiran I, et al. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Experiment Immunol. 2005;140(2):230–240.
   Web of Science ®Google Scholar
• Neumann H, Daly MJ. Variant TREM2 as risk factor for Alzheimer’s disease. N Engl J Med. 2013;368(2):182–184.
   Web of Science ®Google Scholar
• Jiang T, Yu J-T, Zhu X-C, et al. TREM2 in Alzheimer’s disease. Mol Neurobiol. 2013;48(1):180–185.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhong L. The merging roles and therapeutic potential of soluble TREM2 in Alzheimer’s disease. Front Aging Neurosci. 2019;11:328.
   Web of Science ®Google Scholar
• Zhao N, Liu CC, Qiao W, et al. Apolipoprotein E, receptors, and modulation of Alzheimer’s Disease. Biol Psychiatry. 2018;83(4):347–357.
   PubMed Web of Science ®Google Scholar
• Liang S, Domon H, Hosur KB, et al. Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech Ageing Dev. 2009;130(8):538–546.
   Web of Science ®Google Scholar
• Raha AA, Henderson JW, Stott SR, et al. Neuroprotective effect of TREM-2 in aging and Alzheimer’s disease model. J Alzheimers Dis. 2017;55(1):199–217.
   PubMed Web of Science ®Google Scholar
• Zhang B, Gaiteri C, Bodea LG, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell. 2013;153:707–720.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Harokopakis E. Porphyromonas gingivalis interactions with complement receptor 3 (CR3): innate immunity or immune evasion? Front Biosci. 2007;12:4547–4557.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Immune evasion strategies of Porphyromonas gingivalis. J Oral Biosc. 2011;53(3):233–240.
   PubMedGoogle Scholar
• Yin C, Ackermann S, Ma Z, et al. ApoE attenuates unresolved inflammation by complex formation with activated C1q. Nat Med. 2019. Ackermann S, Ma Z, et al. Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019; 25(3):496–529.
   Web of Science ®Google Scholar
• Cunningham C, Wilcockson DC, Campion S, et al. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci. 2005;25(40):9275–9284.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Ide M, Shibutani T, et al. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res. 2006;83(4):557–566.
   Web of Science ®Google Scholar
• Chen J, Buchanan JB, Sparkman NL, et al. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brian Behav Immun. 2008;18:223–230.
   Google Scholar
• Henry CJ, Huang Y, Wynne AM, et al. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2009;23(3):309–317.
   PubMed Web of Science ®Google Scholar
• Wu Z, Ni J, Liu Y, et al. Cathepsin B plays a critical role in inducing Alzheimer’s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun. 2017;65:350–361.
   Web of Science ®Google Scholar
• Zhang J, Yu C, Zhang X, et al. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice. J Neuroinflammation. 2018;15(1):37.
   PubMed Web of Science ®Google Scholar
• Bellinger FP, Madamba S, Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 1993;628:227–234.
   Web of Science ®Google Scholar
• Mishra A, Kim HJ, Shin AH, et al. Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012;7(3):571–578.
   Web of Science ®Google Scholar
• Memedovski Z, Czerwonka E, Han J, et al. Classical and alternative activation of rat microglia treated with ultrapure Porphyromonas gingivalis lipopolysaccharide in vitro. Toxins (Basel). 2020;12(5):333.
   Web of Science ®Google Scholar
• Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2016;173(4):649–665.
   PubMed Web of Science ®Google Scholar
• Yu S, Ding L, Liang D, et al. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice. Mol Oral Microbiol. 2018;33(5):388–395.
   Web of Science ®Google Scholar
• Yang X, Xu S, Qian Y, et al. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury. Brain Behav Immun. 2017;64:162–172.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang J, Nakanishi H. Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J Neuroimmunol. 2005;167(1–2):90–98.
   Web of Science ®Google Scholar
• Wu Z, Hayashi Y, Zhang J, et al. Involvement of prostaglandin E2 released from leptomeningeal cells in increased expression of transforming growth factor-β in glial cells and cortical neurons during systemic inflammation. J Neurosci Res. 2007;85(1):184–192.
   Web of Science ®Google Scholar
• Wu Z, Tokuda Y, Zhang XW, et al. Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol Dis. 2008;32(3):543–551.
   Web of Science ®Google Scholar
• Liu Y, Wu Z, Zhang X, et al. Leptomeningeal cells transduce peripheral macrophages inflammatory signal to microglia in response to Porphyromonas gingivalis LPS. Mediators Inflammation. 2013;2013:407562.
   PubMed Web of Science ®Google Scholar
• Wu Z, Nakanishi H. Connection between periodontitis and Alzheimer’s disease: possible roles of microglia and leptomeningeal cells. J Pharmacol Sci. 2014;126(1):8–13.
   PubMed Web of Science ®Google Scholar
• Siddiqui H, Eribe ERK, Singhrao SK, et al. High throughput sequencing detects gingivitis and periodontal oral bacteria in Alzheimer’s disease autopsy brains. Neuro Res. 2019;1(1):3.
   Google Scholar